Toshimi Kimura

1.8k total citations
62 papers, 1.1k citations indexed

About

Toshimi Kimura is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Toshimi Kimura has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 23 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Toshimi Kimura's work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antifungal resistance and susceptibility (8 papers). Toshimi Kimura is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (28 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antifungal resistance and susceptibility (8 papers). Toshimi Kimura collaborates with scholars based in Japan, United States and United Kingdom. Toshimi Kimura's co-authors include Yoshio Takesue, Kazuaki Matsumoto, Yukihiro Hamada, Yoshiko Takahashi, Satoshi Fujii, Kazutaka Oda, Hiroshige Mikamo, Yusuke Tanigawara, Shunji Takakura and Norio Ohmagari and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Chemistry and Frontiers in Microbiology.

In The Last Decade

Toshimi Kimura

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshimi Kimura Japan	17	731	613	322	281	128	62	1.1k
Yukihiro Hamada Japan	19	780 1.1×	563 0.9×	426 1.3×	305 1.1×	43 0.3×	102	1.4k
Brenda Jones United States	12	1.0k 1.4×	484 0.8×	609 1.9×	279 1.0×	82 0.6×	22	1.4k
Michael Van Guilder United States	11	334 0.5×	481 0.8×	213 0.7×	149 0.5×	135 1.1×	15	869
Dennis J. Stalker United States	12	675 0.9×	570 0.9×	141 0.4×	299 1.1×	56 0.4×	21	1.2k
Sara Baldelli Italy	23	583 0.8×	353 0.6×	178 0.6×	103 0.4×	331 2.6×	67	1.3k
Kazuro Ikawa Japan	23	565 0.8×	1.2k 2.0×	735 2.3×	206 0.7×	115 0.9×	127	1.9k
Norifumi Morikawa Japan	19	486 0.7×	892 1.5×	535 1.7×	160 0.6×	73 0.6×	101	1.4k
Edith Lackner Austria	19	167 0.2×	442 0.7×	232 0.7×	154 0.5×	66 0.5×	46	1.4k
Sihem Benaboud France	20	390 0.5×	574 0.9×	472 1.5×	77 0.3×	268 2.1×	69	1.3k
Sean N. Avedissian United States	16	425 0.6×	554 0.9×	290 0.9×	126 0.4×	41 0.3×	51	962

Countries citing papers authored by Toshimi Kimura

Since Specialization

Citations

This map shows the geographic impact of Toshimi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshimi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshimi Kimura more than expected).

Fields of papers citing papers by Toshimi Kimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshimi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshimi Kimura. The network helps show where Toshimi Kimura may publish in the future.

Co-authorship network of co-authors of Toshimi Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Toshimi Kimura. A scholar is included among the top collaborators of Toshimi Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshimi Kimura. Toshimi Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kasai, Hidefumi, et al.. (2024). Drug–drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model. Frontiers in Microbiology. 15. 1480874–1480874.

Oda, Kazutaka, Kazuaki Matsumoto, Akari Shigemi, et al.. (2024). Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application. Journal of Infection and Chemotherapy. 30(12). 1244–1251. 1 indexed citations

Oda, Kazutaka, Tomoyuki Yamada, Kazuaki Matsumoto, et al.. (2023). Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study. Clinical and Translational Science. 16(11). 2265–2275. 11 indexed citations

Sasano, Hiroshi, Mai Suzuki, Yoko Tabe, et al.. (2023). Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team. International Journal of General Medicine. Volume 16. 3713–3719. 2 indexed citations

Oda, Kazutaka, Tomoyuki Yamada, Kazuaki Matsumoto, et al.. (2023). Model‐informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration‐time curve: A simulation study. Clinical and Translational Science. 16(4). 704–713. 3 indexed citations

Hanai, Yuki, Takashi Ueda, Yukihiro Hamada, et al.. (2023). Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients. Mycoses. 66(12). 1035–1044. 6 indexed citations

Kimura, Toshimi, et al.. (2023). Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection. Journal of Infection and Chemotherapy. 29(12). 1152–1159. 2 indexed citations

Takesue, Yoshio, Yuki Hanai, Kazutaka Oda, et al.. (2022). Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clinical Therapeutics. 44(12). 1604–1623. 37 indexed citations

Matsumoto, Kazuaki, Kazutaka Oda, Kensuke Shoji, et al.. (2022). Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Pharmaceutics. 14(3). 489–489. 78 indexed citations

10.

Ueda, Takashi, Yoshio Takesue, Kazuhiko Nakajima, et al.. (2022). Validation of Vancomycin Area under the Concentration—Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics. 11(1). 96–96. 21 indexed citations

11.

Hamada, Yukihiro, et al.. (2022). Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan. International Journal of Environmental Research and Public Health. 19(5). 2516–2516. 3 indexed citations

12.

Hanai, Yuki, Yukihiro Hamada, Toshimi Kimura, et al.. (2021). Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis. Journal of Fungi. 7(4). 306–306. 24 indexed citations

13.

Mizukami, Yuki, Yuki Enoki, Kazuaki Taguchi, et al.. (2021). The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses. Journal of Infection and Chemotherapy. 27(5). 781–785. 4 indexed citations

14.

Hanai, Yuki, Yoshiko Takahashi, Takashi Niwa, et al.. (2021). Optimal trough concentration of teicoplanin for the treatment of methicillin‐resistant Staphylococcus aureus infection: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics. 46(3). 622–632. 17 indexed citations

15.

Hanai, Yuki, Yukihiro Hamada, Toshimi Kimura, et al.. (2020). Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis. Journal of Infection and Chemotherapy. 27(2). 151–160. 20 indexed citations

16.

Shiga, Tsuyoshi, et al.. (2018). <b>Cardiac Arrest in an Elderly Cancer Patient Arrhythmia Receiving Flecainide </b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 49(4). 169–172.

17.

Takesue, Yoshio, Yusuke Tanigawara, Hiroshige Mikamo, et al.. (2010). Therapeutic drug monitoring survey of anti-MRSA agents in Japan. 58(2). 119–124. 4 indexed citations

18.

Kimura, Toshimi, et al.. (2003). Population pharmacokinetics of arbekacin in pediatric patients.. Chemotherapy. 51(1). 18–23. 2 indexed citations

19.

Kimura, Toshimi, et al.. (2000). Determination of Plasma Panipenem Concentration in Neonates by High-Performance Liquid Chromatography.. Japanese Journal of Hospital Pharmacy. 26(5). 505–509. 1 indexed citations

20.

Kimura, Toshimi. (1995). Population Pharmacokinetics of gentamicin.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 26(1). 189–190. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact